PRISM BioLab Co.,LTD (206A.T)
JPY 292.0
(-1.68%)
JPY 292.0
(-1.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -526.91 Million JPY | -822.18% |
| 2022 | 72.96 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -233.49 Million JPY | 0.0% |
| 2023 FY | -526.91 Million JPY | -822.18% |
| 2022 FY | 72.96 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 237.217% |
| GNI Group Ltd. | 8.09 Billion JPY | 106.51% |
| Linical Co., Ltd. | 338.26 Million JPY | 255.769% |
| Trans Genic Inc. | 4.08 Million JPY | 12998.752% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 63.357% |
| Soiken Holdings Inc. | -662.2 Million JPY | 20.43% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 481.393% |
| AnGes, Inc. | -7.43 Billion JPY | 92.916% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 59.095% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 92.675% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 382.234% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 32.447% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 54.296% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 56.417% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 35.142% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -62.798% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 56.811% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 62.948% |
| PeptiDream Inc. | 3.03 Billion JPY | 117.356% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 72.819% |
| Ribomic Inc. | -1.02 Billion JPY | 48.555% |
| SanBio Company Limited | -2.64 Billion JPY | 80.071% |
| Healios K.K. | -3.82 Billion JPY | 86.217% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 54.891% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 64.627% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 63.137% |
| StemRIM | -2.02 Billion JPY | 73.941% |
| CellSource Co., Ltd. | 923.14 Million JPY | 157.078% |
| FunPep Company Limited | -933.41 Million JPY | 43.55% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 38.311% |
| Stella Pharma Corporation | -763.74 Million JPY | 31.01% |
| TMS Co., Ltd. | -960.04 Million JPY | 45.115% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 53.371% |
| Cuorips Inc. | -632.18 Million JPY | 16.652% |
| K Pharma,Inc. | 260.33 Million JPY | 302.402% |
| Takara Bio Inc. | 1.48 Billion JPY | 135.602% |
| ReproCELL Incorporated | -31.41 Million JPY | -1577.269% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 2097.551% |
| StemCell Institute Inc. | 310.98 Million JPY | 269.436% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 468.036% |
| CellSeed Inc. | -846.53 Million JPY | 37.756% |